Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Natl Med Assoc ; 116(1): 6-12, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38052698

ABSTRACT

INTRODUCTION: Part of the difficulty in recruiting and retaining a diverse physician workforce, as well as within medical leadership, is due to racial disparities in medical education. We investigated whether self-identified race-ethnicity is associated with the likelihood of selection as chief resident (CR). MATERIALS AND METHODS: We performed a cross sectional analysis using de-identified person-level data from the GME Track, a national resident database and tracking system, from 2015 through 2018. The exposure variable, self-identified race-ethnicity, was categorized as African American or Black, American Indian or Alaskan Native, Asian, Hispanic, Latino or of Spanish Origin, Native Hawaiian or Pacific Islander, White, and Multi-racial. The primary study outcome was CR selection among respondents in their final program year. Logistic regression was used to estimate the adjusted odds ratios (aOR) and 95% confidence intervals (CI) of CR selection for each racial group, as compared to the White referent group. RESULTS: Among the study population (N=121,247), Black, Asian and Hispanic race-ethnicity was associated with a significantly decreased odds of being selected as CR in unadjusted and adjusted analyses. Black, Asian and Hispanic residents had a 26% (aOR=0.74, 95% CI 0.66-0.83), 29% (aOR=0.71, 95% CI 0.66-0.76) and 28% (aOR=0.72, 95% CI 0.66-0.94) decreased likelihood of becoming CR, respectively. Multi-racial residents also had a decreased likelihood, but to a lesser degree (aOR=0.92, 95% CI 0.89-0.95). CONCLUSIONS: In as much as CR is an honor that sets one up for future opportunity, our findings suggest that residents of color are disproportionately disadvantaged compared to their White peers.


Subject(s)
Ethnicity , Internship and Residency , Racial Groups , Racism , Humans , Cross-Sectional Studies , Ethnicity/statistics & numerical data , Hispanic or Latino/statistics & numerical data , Racial Groups/statistics & numerical data , United States/epidemiology , White , Racism/ethnology , Racism/statistics & numerical data , Internship and Residency/statistics & numerical data , Asian/statistics & numerical data , American Indian or Alaska Native/statistics & numerical data , Black or African American/statistics & numerical data
2.
Am J Obstet Gynecol ; 229(5): 551.e1-551.e6, 2023 11.
Article in English | MEDLINE | ID: mdl-37315753

ABSTRACT

BACKGROUND: Despite the known benefits of breastfeeding to infants and mothers, previous studies have demonstrated that underserved women are less likely to exclusively breastfeed. Existing studies on the impact of Special Supplemental Nutritional Program for Women, Infants, and Children enrollment on feeding decisions for infants have conflicting results with low-quality data and metrics. OBJECTIVE: This study aimed to examine infant feeding trends nationally in the first week postpartum over a 10-year period, comparing breastfeeding rates for primiparous women with low income who used Special Supplemental Nutritional Program for Women, Infants, and Children resources with those women who did not enroll. We hypothesized that although the Special Supplemental Nutritional Program for Women, Infants, and Children is an important resource for new mothers, free formula associated with enrollment in the Special Supplemental Nutritional Program for Women, Infants, and Children may disincentivize women to exclusively breastfeed. STUDY DESIGN: This was a retrospective cohort study of primiparous women with singleton gestations who gave birth at term and who responded to the Centers for Disease Control and Prevention Pregnancy Risk Assessment Monitoring System between 2009 and 2018. Data were extracted from phases 6, 7, and 8 of the survey. Women with low income were defined as those with a reported annual household income of $35,000 or less. The primary outcome was exclusive breastfeeding after 1 week postpartum. Secondary outcomes included ever breastfeeding, any breastfeeding after 1 week postpartum, and introduction of other liquids within 1 week postpartum. Multivariable logistic regression was used to refine risk estimates with adjustment for mode of delivery, household size, education level, insurance status, diabetes, hypertension, race, age, and BMI. RESULTS: Among the 42,778 women with low income who were identified, 29,289 (68%) of these women reported receiving Special Supplemental Nutritional Program for Women, Infants, and Children resources. There was no significant difference in the rates of exclusive breastfeeding after 1 week postpartum between those enrolled in the Special Supplemental Nutritional Program for Women, Infants, and Children and those not enrolled (adjusted risk ratio, 1.04; 95% confidence interval, 1.00-1.07; P=.10). However, those enrolled were less likely to ever breastfeed (adjusted risk ratio, 0.95; 95% confidence interval, 0.94-0.95; P<.01) and were more likely to introduce other liquids within 1 week postpartum (adjusted risk ratio, 1.16; 95% confidence interval, 1.11-1.21; P<.01). CONCLUSION: Although exclusive breastfeeding rates after 1 week postpartum were similar, women enrolled in the Special Supplemental Nutritional Program for Women, Infants, and Children were significantly less likely to ever breastfeed and more likely to introduce formula within the first week postpartum. This suggests that Special Supplemental Nutritional Program for Women, Infants, and Children enrollment may impact the decision to initiate breastfeeding and may represent an important window to test future interventions.


Subject(s)
Breast Feeding , Mothers , Pregnancy , Infant , Female , United States , Child , Humans , Retrospective Studies , Postpartum Period , Surveys and Questionnaires
3.
Am J Obstet Gynecol MFM ; 5(5): 100919, 2023 05.
Article in English | MEDLINE | ID: mdl-36894056

ABSTRACT

BACKGROUND: Racial and ethnically minoritized individuals and women are underrepresented in leadership roles in academic medicine. Little is known about whether and to what extent these racial and sex disparities exist in graduate medical education. OBJECTIVE: This study aimed to determine whether race-ethnicity or the intersection of race-ethnicity and sex impact the likelihood of being selected as chief resident in obstetrics and gynecology residency programs. STUDY DESIGN: We performed cross-sectional analyses using data from Graduate Medical Education Track, a national resident database and tracking system. Those included in this analysis were final-year obstetrics and gynecology residents in US-based residency programs from 2015 to 2018. The exposure variables were self-reported race-ethnicity and sex. The outcome was being selected as chief resident. A logistic regression was used to estimate the odds of being selected as chief resident. We tested the following variables for potential confounding: survey year, United States citizenship, medical school type, geographic region of residency, and Alpha Omega Alpha status. RESULTS: There were 5128 residents included. Black residents were 21% less likely to be selected as chief resident than White residents (odds ratio, 0.79; 95% confidence interval, 0.65-0.96). Females were 19% more likely to be chief resident than males (odds ratio, 1.19; 95% confidence interval, 1.02-1.38). When examining the intersection of race-ethnicity and sex, the results revealed some heterogeneity. Among males, Black individuals had the lowest odds of being selected as chief resident (odds ratio, 0.32; 95% confidence interval, 0.17-0.63; referent White males), whereas among females, Hispanic individuals were the least likely to be selected as chief resident (odds ratio, 0.69; 95% confidence interval, 0.52-0.92; referent White females). White females were almost 4 times more likely to be selected as chief resident than Black males (odds ratio, 3.79; 95% confidence interval, 1.97-7.29). CONCLUSION: The odds of being selected as chief resident differ significantly by race-ethnicity, sex, and the intersection of these factors.


Subject(s)
Gynecology , Internship and Residency , Obstetrics , Male , Pregnancy , Humans , Female , United States/epidemiology , Cross-Sectional Studies , Ethnicity
4.
J Assist Reprod Genet ; 39(6): 1367-1371, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35428959

ABSTRACT

PURPOSE: In vitro fertilization (IVF) has been a well-established method for treating infertility for over four decades. The mainstay method of culture of oocytes and embryos has been in gas incubators. More recently, the novel use of a gas-permeable closed vessel to culture oocytes and embryos in the vagina, intravaginal culture (IVC), has been introduced as a viable lower-cost option for infertility patients. Several studies have studied the efficacy of IVC; however, there is no data on the perinatal outcomes of the babies born using this newer technology. METHODS: Our study is a retrospective case series (n = 66) from a single center, uniquely examining the perinatal outcomes of infants born after IVC. RESULTS: There were 50 singleton and 16 twin gestations in this case series. For singleton infants conceived via IVC (n = 50), the mean gestational age at delivery was 38 weeks and 4 days, and the mean birth weight was 3159.1 + / - 501.5 g. Four infants were born with low birth weight, three were born preterm, and one was born macrosomic. The twin pregnancies had a mean gestational age at delivery of 33 weeks 4 days and a mean birth weight of 1992.9 + / - 620.7 g. Twenty-seven infants met the criteria for low birthweight, and twenty-four infants delivered preterm. No twin infants met the criteria for macrosomia. CONCLUSION: This case series provides an initial description of the perinatal outcomes of IVC conceived infants, which shows no concerning trends in adverse birth outcomes for singleton infants. As expected, IVC twin gestations had a high rate of low birth weight and preterm delivery. Continued larger studies are essential to provide more comprehensive data on perinatal outcomes of infants conceived by this new technology.


Subject(s)
Infertility , Premature Birth , Birth Weight , Female , Fertilization in Vitro , Humans , Infant, Newborn , Infant, Premature , Population Surveillance , Pregnancy , Pregnancy Outcome , Pregnancy, Twin , Reproductive Techniques, Assisted , Retrospective Studies
5.
J Womens Health (Larchmt) ; 31(12): 1805-1811, 2022 12.
Article in English | MEDLINE | ID: mdl-33646020

ABSTRACT

Background: Pregnancy loss is the most common complication of pregnancy and understanding the needs of individuals experiencing pregnancy loss will help the medical team provide patient-centered care. Few studies address differences in needs of individuals regarding timing of pregnancy losses and number of losses. Methods: An anonymous nine-question survey assessing the experience and immediate needs of individuals who have had pregnancy loss. Results: The survey response was high (79%; 793/1000). 75.8% of the respondents experienced first trimester losses, and 55.0% experienced more than one pregnancy loss. Respondents with three or more losses were more likely to see a reproductive endocrinologist compared to those experiencing one loss (15.7% vs. 6.4%, p < 0.01). The highest-ranked need among all respondents (45.5%) was understanding why their pregnancy loss occurred followed by family support (26.8%). However, those who had more than three losses or first trimester losses ranked preventing a future pregnancy loss over family support. Respondents with three or more losses more frequently desired a referral to a pregnancy loss team (37.5% vs. 79.7%, p < 0.001). A qualitative analysis of respondents' comments on how to provide patient-centered care revealed five major themes; the most frequently mentioned theme was staff preparedness, competence, and availability. Conclusion: Our survey highlights the overwhelming importance to individuals who have had pregnancy loss of finding a cause for their loss, regardless of gestational age/multiple losses. Referral to a dedicated pregnancy loss provider/team is highly desired. Finally, patients value sensitivity, compassion, and emotional support from their physicians and their staff.


Subject(s)
Abortion, Spontaneous , Pregnancy , Female , Humans , Retrospective Studies , Abortion, Spontaneous/epidemiology , Surveys and Questionnaires , Gestational Age , Counseling
6.
J Racial Ethn Health Disparities ; 9(2): 684-690, 2022 Apr.
Article in English | MEDLINE | ID: mdl-33646554

ABSTRACT

BACKGROUND: Hispanic patients have previously been shown to have relatively lower odds of complication following hysterectomy compared with non-Hispanic white patients, but little is known about specific risks for this group. Our primary objective was to identify differences in proportions of specific complications experienced by Hispanic patients following hysterectomy for benign indications as compared with non-Hispanic white patients. DESIGN: Retrospective cohort study examining differences in complication rates following benign hysterectomy between Hispanic and non-Hispanic white patients in NSQIP-participating hospitals from 2012 to 2016. MEASUREMENTS AND MAIN RESULTS: A total of 102,051 women were included. A total of 15.0% were Hispanic and 85.0% were non-Hispanic white. Hispanic patients were more likely to have class 1 or 2 obesity (59.7 vs 49.8%), diabetes (10.9 vs 6.7%), and anemia (hematocrit < 33: 14.1 vs 6.5%); p < 0.01 for all. Hispanic patients were more likely to undergo abdominal hysterectomy (30.0 vs 19.1%, p < 0.01) and to remain inpatient for 2-6 days (38.8 vs 24.0%, p < 0.01). After adjustment for possible confounders including anemia, an increased odds of requiring blood transfusion persisted only in the laparoscopic and vaginal groups. Hispanic patients had a decreased or equal odds for all other examined complications. CONCLUSIONS: Compared with non-Hispanic white patients, Hispanic women had a higher odds of requiring blood transfusion even when undergoing minimally invasive laparoscopic and vaginal approaches to hysterectomy. Despite a higher proportion of open surgery, Hispanic patients had a decreased or equal odds of postoperative complications.


Subject(s)
Anemia , Laparoscopy , Anemia/etiology , Female , Hispanic or Latino , Humans , Hysterectomy , Laparoscopy/adverse effects , Male , Retrospective Studies
7.
J Assist Reprod Genet ; 38(5): 1055-1060, 2021 May.
Article in English | MEDLINE | ID: mdl-33534048

ABSTRACT

PURPOSE: To determine the effect of human growth hormone (GH) supplementation during ovarian stimulation in women undergoing IVF/PGT-A cycles, who do not meet the Bologna criteria for poor ovarian response (POR). METHODS: This is a retrospective cohort study of 41 women with suboptimal outcomes in their first cycle of IVF/PGT-A including lower than expected number of MII oocytes, poor blastulation rate, and/or lower than expected number of euploid embryos for their age, who underwent a subsequent IVF/PGT-A cycle with the same fixed dose gonadotropin protocol and adjuvant GH treatment. Daily cotreatment with GH started with first gonadotrophin injection. The IVF cycle outcomes were compared between the control and GH cycle using the Wilcoxon-Signed Rank test. RESULTS: The total number of biopsied blastocysts (mean ± SD; 2.0 ± 1.6 vs 3.5 ± 3.2, p = 0.009) and euploid embryos (0.8 ± 1.0 vs 2.0 ± 2.8, p = 0.004) were significantly increased in the adjuvant GH cycle compared to the control cycle. The total number of MII oocytes also trended to be higher in the GH cycle (10.2 ± 6.3 vs 12.1 ± 8.3, p = 0.061). The overall blastulation and euploidy rate did not differ between the control and treatment cycle. CONCLUSION: Our study uniquely investigated the use of adjuvant GH in IVF/PGT-A cycles in women without POR and without a priori suspicion for poor outcome based on their clinical parameters. Our study presents preliminary evidence that GH supplementation in these women is beneficial and is associated with an increased number of blastocysts for biopsy and greater number of euploid embryos for transfer.


Subject(s)
Fertilization in Vitro , Growth Hormone/therapeutic use , Oocytes/drug effects , Ovulation Induction/trends , Adult , Birth Rate/trends , Dietary Supplements , Female , Humans , Live Birth/epidemiology , Oocytes/growth & development , Pregnancy , Pregnancy Rate , Sperm Injections, Intracytoplasmic/trends
SELECTION OF CITATIONS
SEARCH DETAIL
...